Back

Circulating beta-hydroxybutyrate levels in advanced HFrEF: the determinants and prognostic impact

26 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Outcomes in heart failure Peripheral Circulation, Metabolism, Skeletal Muscle ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Vojtech Melenovsky

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

6 More presentations in this session

Presentation thumbnail
Impact of patient characteristics on heart failure and cardiomyopathy onset related to pregnancy from 1997 to 2019. Swedish nationwide register-based study.
Doctor C. Basic (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Educational level and risk of all-cause death in patients with heart failure with reduced ejection fraction (HFrEF): a report from the WARCEF Trial
Doctor B. Corica (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Impact of left atrial dysfunction on mortality in patients with atrial fibrillation and heart failure
Doctor J. Yamamoto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Echocardiography-based risk score predicts cardiovascular outcomes in ischemic heart failure patients with reduced ejection fraction
Doctor K. Hu (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Anemia and 1-year outcomes in hospitalized patients with heart failure with preserved ejection fraction: Findings from the China Cardiovascular Association Database-Heart Failure Center Registry
Doctor A. Cai (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes in heart failure

The Event

Event poster

ESC Congress 2023

26 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Circulating beta-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction
thumbnail
Congress Presentation
Higher myocardial mitochondrial ketone body oxidation capacity in human heart failure
thumbnail
Congress Presentation
Ketone body ratio as a predictor of heart failure incidence: findings from a 15-year longitudinal cohort study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources